NCT05891912

Brief Summary

Clinical trial with users of health care centres and nursing homes in Extremadura (Spain). Inclusion criteria are: women and men over 55 years of age with a Minimental State Examination (MMSE) equal or higher than 21 (no cognitive impairment or mild to moderate cognitive impairment) who are able to walk independently. Exclusion criteria are: patients with severe cognitive impairment or language impairment that prevents the use of verbal communication, non-autonomous gait and severe limitation of mobility at the level of the upper limb. Treatment schedule: 30 min sessions, twice a week during 12 weeks

  • 1 session per week: 15min small TABLET and 15min LIGHTS game.
  • 1 session per week: 15min TABLE TABLET and 15min game of grape harvesting. The intervention will be carried out by occupational therapists or physiotherapists. The intervention period and evaluations will be performed as follows:
  • Training of Occupational therapists/physiotherapists: 1 week prior to the start of the intervention for.
  • Week 0- Initial measurements
  • Week 1-12: device interventions
  • Week 13: Final measurements
  • Week 17: First follow-up measurement
  • Week 21: Second follow-up measurement

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 15, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

June 7, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

May 15, 2023

Last Update Submit

May 26, 2023

Conditions

Keywords

older adults,

Outcome Measures

Primary Outcomes (4)

  • Change from the cognitive impairment measured with the Minimental State Examination at 13 weeks , 17 weeks and 21 weeks

    The Mini-Mental State Examination (MMSE) is a set of 11 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment. Any score of 24 or more (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment.

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from the Activities of daily living performance measured with the Barthel Index at 13 weeks , 17 weeks and 21 weeks

    The Barthel Scale/Index is an ordinal scale used to measure performance in activities of daily living (ADL). Ten variables describing ADL and mobility are scored, a higher number being a reflection of greater ability to function independently following hospital discharge. Each item is rated in terms of whether the patient can perform the task independently, with some assistance, or is dependent on help based on observation (0=unable, 1=needs help, 2=independent). The final score is x 5 to get a number on a 100 point score. Proposed guidelines for interpreting Barthel scores are that scores of 0-20 indicate "total" dependency, 21-60 indicate "severe" dependency, 61-90 indicate "moderate" dependency, and 91-99 indicates "slight" dependency.2 Most studies apply the 60/61 cutting point.

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from the Depression level measured with the Yesavage Geriatric Depression Scale (GDS) at 13 weeks , 17 weeks and 21 weeks

    The The Yesavage Geriatric Depression Scale (GDS) is an assessment tool for diagnosing depression in older adults and expresses the degree of satisfaction, quality of life and feelings. (GDS) is an assessment tool for diagnosing depression in older adults and expresses the degree of satisfaction, quality of life and feelings. Scores of 0-4 are considered normal, depending on age, education, and complaints; 5-8 indicate mild depression; 9-11 indicate moderate depression; and 12-15 indicate severe depression.

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from Instrumental Activities of Daily Living performance measured with The Lawton Instrumental Activities of Daily Living (IADL) Scale at 13 weeks , 17 weeks and 21 weeks

    The Lawton Instrumental Activities of Daily Living Scale (IADL) is an appropriate instrument to assess independent living skills. These skills are considered more complex than the basic activities of daily living as measured by the Katz Index of ADLs (See Try this: Katz Index of ADLs). The instrument is most useful for identifying how a person is functioning at the present time, and to identify improvement or deterioration over time. There are eight domains of function measured with the Lawton IADL scale. Scores range from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men.

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

Secondary Outcomes (4)

  • Change from the balance and gait performance measured with the Tinetti test at 13 weeks , 17 weeks and 21 weeks

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from the upper limb range of movement at 13 weeks , 17 weeks and 21 weeks

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from the Reaction speed or number of attempts during the sessions at 13 weeks , 17 weeks and 21 weeks

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

  • Change from the Number of correct tries in each game at 13 weeks , 17 weeks and 21 weeks

    It will be measured at week 0 (pre-intervention), week 13 (post-intervention), week 17 (follow up)and week 21 (follow up)

Study Arms (1)

Technological devices intervention

EXPERIMENTAL

The intervention will be in individual sessions with the following technological devices and games: * Vertical screen: game of lights and vintage game. * Horizontal screen: cognitive function and activities of daily living games * Tablets: cognitive function and activities of daily living games

Other: Technological devices intervention (use of tablet and big screen with games oriented to training physical and cognitive function)

Interventions

The treatment will be performed in 30 min sessions, twice a week during 12 weeks. the weekly sessions will include the following games: * 1 session per week: 15min small TABLET and 15min LIGHTS game. * 1 session per week: 15min TABLE TABLET and 15min game of VINTAGE.

Technological devices intervention

Eligibility Criteria

Age50 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women and men over 50 years of age
  • Minimental State Examination (MMSE) equal or higher than 21 (no cognitive impairment or mild to moderate cognitive impairment)
  • Independent gait

You may not qualify if:

  • patients with severe cognitive impairment or language impairment that prevents the use of verbal communication
  • No independent gait
  • Severe limitation of upper limb range of movement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Extremadura

Cáceres, Extremadura, 10003, Spain

RECRUITING

Central Study Contacts

ELISA MARIA GARRIDO-ARDILA, PhD

CONTACT

Maria Trinidad Rodríguez-Dominguez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The assessors will be independent to the study and will be blinded to the treatment received by the patients.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a pre-test post-test study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 15, 2023

First Posted

June 7, 2023

Study Start

April 1, 2023

Primary Completion

September 1, 2023

Study Completion

November 1, 2023

Last Updated

June 7, 2023

Record last verified: 2023-05

Locations